Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Shibuki T, Hoyek C, Ramaker R, Gottam M, Ueno M, Kawamoto Y, Itoh S, Inoue K, Hashimoto T, Fujisawa T, Imai M, Nakamura Y, Bando H, Pirozzi A, Zheng-Lin B, Abidoye O, Eslinger CR, Sonbol MB, Babiker H, Tran N, Morizane C, Strickler JH, Yoshino T, Bekaii-Saab T, Ikeda M